Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A fascinating new paper based on data from the Prostate Cancer DataBase Sweden provides important insight into the consequences of delayed diagnosis and potential under-treatment of men who are diagnosed with locally advanced prostate cancer.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: delayed, Diagnosis, locally advanced, mortality, prostate cancer-specific | 14 Comments »
One of the major debates about the appropriate management of prostate cancer is whether deferral of treatment by low-risk patients is or is not associated with an increase in risk for disease progression and prostate cancer-specific mortality post-treatment.
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: deferred, delayed, outcome, surgery | 3 Comments »
In March this year we reported briefly on an article by Van Poppel et al. reviewing available data on the adjuvant and the delayed use of hormone therapy in the treatment of prostate cancer and the related issue of PSA recurrence (particularly in high risk patients).
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, ADT, androgen deprivation therapy, delayed, immediate | Leave a Comment »
The most important piece of news today is the publication of the final result of the EORTC 30846 study comparing early and delayed hormone therapy. Other news includes: The hypothesis that fatty acid levels affect prostate cancer risk Prostate cancer risk based on a single PSA level Surgical treatment of men with T3-4 disease Early stage [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: delayed, fat, immediate, PSA, risk, surgery, Treatment, vaccine | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site